Skip to main content
. 2010 Dec 1;5(12):e14196. doi: 10.1371/journal.pone.0014196

Table 1. Clinical characteristics of the study population.

Total1 Male2 Female2 P value3
N 243 118 125 NS
Age* 61.0±11.5 60.9±11.2 61.2±11.9 NS
Smoking 68 (28.0) 39 (33.1) 29 (23.2) NS
Diabetes 30 (12.3) 14 (11.9) 16 (12.8) NS
Hypertension 96 (39.5) 43 (36.4) 53 (42.4) NS
Prior myocardial infarction (MI) 49 (20.2) 31 (26.3) 18 (14.4) 0.002
Prior revascularisation (revasc.) 19 (12.8) 14 (9.7) 5 (2.9) <0.001
Known CAD (MI or revasc.) 68 (28.0) 45 (38.1) 23 (18.4) <0.001
Medication:
Beta-blockers 121 (49.8) 66 (55.9) 55 (44.0) NS
Calcium antagonists 49 (20.2) 24 (20.3) 25 (20.0) NS
ACE-inhibitors 80 (32.9) 43 (36.4) 37 (29.6) NS
Diuretics 79 (32.5) 35 (29.7) 44 (35.2) NS
Statins 111 (45.7) 67 (56.8) 44 (35.2) <0.001
Paraclinic:
Body Mass Index* 27.7±4.9 28.3±4.3 27.2±5.4 NS
Resting heart rate, bpm* 74.0±12.9 72.1±12.5 75.8±13.1 0.02
Systolic blood pressure, mmHg* 146±23 146±22 147±25 NS
Diastolic blood pressure, mmHg* 87±13 88±13 86±13 NS
Creatinine, µmol/l* 83±21 93±18 75±19 <0.001
Total cholesterol, mmol/l* 5.3±1.3 5.2±1.3 5.4±1.2 NS
HDL, mmol/l* 1.5±0.5 1.3±±0.4 1.7±0.6 <0.001
LDL, mmol/l* 3.0±1.1 3.0±1.2 3.1±1.0 NS
Stress type at MPI:
Ergometer exercise 132 (54.3) 72 (61.0) 60 (48.0) NS
Dypyridamole 105 (43.2) 43 (36.4) 63 (50.4) <0.001
Dobutamine stress 6 (2.5) 3 (2.5) 3 (2.4) NS
Heart dimensions, post stress:
EF, % ** 64 (57–70) 59 (51–64) 68 (64–74) <0.001
EF < lower normal limit*** 19 (7.8) 12 (10.2) 7 (5.6) <0.001
ESV index < lower normal limit, ml/m2 0 (0.0) 0 (0.0) 0 (0.0) NS
Results of MPI:
Normal MPI 199 (81.9) 84 (71.2) 115 (92.0) <0.001
Abnormal MPI 44 (18.1) 34 (28.8) 10 (8.0) <0.001
*

Mean (SD),

**

median (IQR), otherwise presented as N (%).

1

Percentage within the total population,

2

percentage within gender,

3

p value for comparison between genders.

Abbreviations: bpm, beats pr. minute; CAD, coronary artery disease; EF, ejection fraction; ESV index, end systolic volume index; MPI, myocardial perfusion imaging.